entrectinib and Low-Back-Pain

entrectinib has been researched along with Low-Back-Pain* in 1 studies

Other Studies

1 other study(ies) available for entrectinib and Low-Back-Pain

Article	Year
Activity of Entrectinib in a Patient With the First Reported Journal of the National Comprehensive Cancer Network : JNCCN, 2017, Volume: 15, Issue:11 Despite advances in genomic analysis, the molecular origin of neuroendocrine tumors (NETs) is complex and poorly explained by described oncogenes. The neurotrophic TRK family, including Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biopsy; Chemotherapy, Adjuvant; Clinical Trials as Topic; Disease Progression; Drugs, Investigational; Exons; High-Throughput Nucleotide Sequencing; Humans; Indazoles; Intestinal Neoplasms; Intestine, Small; Low Back Pain; Male; Neoplasm Grading; Neuroendocrine Tumors; Oncogene Proteins, Fusion; Palliative Care; Positron-Emission Tomography; Protein Kinase Inhibitors; Radiotherapy; Response Evaluation Criteria in Solid Tumors; Sequence Analysis, RNA; Treatment Outcome	2017

Article

Year

Activity of Entrectinib in a Patient With the First Reported

Journal of the National Comprehensive Cancer Network : JNCCN, 2017, Volume: 15, Issue:11

Despite advances in genomic analysis, the molecular origin of neuroendocrine tumors (NETs) is complex and poorly explained by described oncogenes. The neurotrophic TRK family, including

Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biopsy; Chemotherapy, Adjuvant; Clinical Trials as Topic; Disease Progression; Drugs, Investigational; Exons; High-Throughput Nucleotide Sequencing; Humans; Indazoles; Intestinal Neoplasms; Intestine, Small; Low Back Pain; Male; Neoplasm Grading; Neuroendocrine Tumors; Oncogene Proteins, Fusion; Palliative Care; Positron-Emission Tomography; Protein Kinase Inhibitors; Radiotherapy; Response Evaluation Criteria in Solid Tumors; Sequence Analysis, RNA; Treatment Outcome

2017